GlassScriptPhysician profile
Tabatha J Cronander
NPI 1851874499
$2,650.38
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $676 · 2023: $881 · 2024: $1,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,974.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $327.11 | 2022-2024 | Ultomiris, Soliris |
| Acadia Pharmaceuticals INC | $324.14 | 2022-2024 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $276.17 | 2023-2024 | Nuedexta, Rexulti |
| Novo Nordisk INC | $226.42 | 2022-2023 | Wegovy |
| Boston Scientific Corporation | $187.46 | 2022-2024 | |
| Abiomed | $139.14 | 2024 | Impella |
| Medtronic, INC. | $135.20 | 2023 | Interstim |
| Neurocrine Biosciences, INC. | $128.54 | 2022 | |
| Gilead Sciences, INC. | $124.99 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.75 | 2024 | Hyqvia |
| Teva Pharmaceuticals USA, INC. | $119.70 | 2024 | Austedo Xr |
| Lundbeck LLC | $115.00 | 2023 | Vyepti |
| Viiv Healthcare Company | $107.10 | 2024 | Dovato |
| Janssen Pharmaceuticals, INC | $97.38 | 2023 | Spravato |
| Amarin Pharma, INC. | $90.92 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $71.78 | 2023 | |
| Scilex Pharmaceuticals INC. | $23.53 | 2023 | Ztlido |
| Averitas Pharma INC. | $19.81 | 2023 | Qutenza |
| Grt US Holding, INC. | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabatha Cronander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.